Antibody Patenting
� A Practitioners Guide to Drafting, Prosecution and Enforcement
Författare:Meier Jürgen , Ridderbusch Oswin , red.
Titel:Antibody Patenting � A Practitioners Guide to Drafting, Prosecution and Enforcement
Upplaga:2 uppl.
Omfång:672 sid.
Förlag:Kluwer Law International
Typ av verk:Samlingsverk
Ämnesord:Immaterialrätt , Processrätt , Internationell rätt

Pris: 2484 SEK exkl. moms


Antibodies have revolutionized medicine and biotechnology, and have become indispensable tools in therapy, diagnostics, analytics, and research. Therapeutic antibodies, for example, have become firmly established in the ranks of blockbuster drugs, currently accounting for about half of the top 10 best-selling medicines. At the same time, a body of case law dealing specifically with the patentability of antibody-related inventions and the enforcement of antibody patents has emerged in major jurisdictions. The, at times, significant divergences between different jurisdictions have been compounded by recent decisions in the United States, which have severely curtailed the possibilities to obtain broad antibody patents. It is therefore essential to understand how antibody inventions are assessed in different jurisdictions in order to secure an optimal patent protection and to successfully enforce such patents.

This book provides practitioners with a comprehensive resource elucidating all aspects of the patenting of antibodies from initial drafting and prosecution to enforcement, using a country-by-country format. The updated and expanded Second Edition covers more than 30 of the most important IP jurisdictions worldwide – i.e., the European Patent Office, Belgium, Denmark, Finland, France, Germany, Hungary, Ireland, Italy, the Netherlands, Poland, Spain, Sweden, Switzerland, the United Kingdom, the United States of America, Canada, Mexico, the Andean Community (Bolivia, Colombia, Ecuador, and Peru), Argentina, Brazil, Chile, China, India, Israel, Japan, Singapore, South Korea, Taiwan, Australia, and New Zealand. The 49 contributors to this book, all distinguished experts in this field, provide clear and practice-oriented advice on a range of topics including:

- Which types of antibody inventions are patent-eligible?

- Which types of functional and structural features are accepted for claiming antibodies?

- What needs to be considered when defining antibodies in terms of their antigen, target affinity, binding specificity, epitope, competitive binding and other characteristics in relation to reference antibodies, as well as their effects on the target?

- Which pitfalls must be avoided when defining amino acid sequences, chemical modifications or glycosylation patterns, and when relying on cell line deposits?

- Which breadth of claims is accepted for antibody inventions, and what experimental support is required?

- Which specific medical applications of antibodies can be claimed?

- How is inventive step assessed in the specific case of antibody inventions?

- What has to be considered when enforcing antibody patents, including in relation to biosimilars as well as the doctrine of equivalence?

All chapters follow the same structure, which makes this book easily accessible and allows a direct comparison between different jurisdictions. Practitioners will find the much-needed tools and guidance to secure the best possible patent protection for antibody inventions in more than 30 of the most important jurisdictions worldwide.

This book is the fifth volume in the AIPPI Law Series which has been established together with the International Association for the Protection of Intellectual Property (AIPPI), a non-affiliated, non-profit organization dedicated to improving and promoting the protection of intellectual property at both national and international levels.

Table Of Contents
About the Editors
About the Contributors

Shoichi Okuyama, President of AIPPI


Jürgen Meier & Oswin Ridderbusch

Chapter 1 European Patent Office
Jürgen Meier, Oswin Ridderbusch & Hans-Rainer Jaenichen

Chapter 2 Belgium
Koen Vanhalst

Chapter 3 Denmark
Jan Mondrup Pedersen & Jakob Schwalbe Lohmann

Chapter 4 Finland
Krister Karlsson

Chapter 5 France
Cyra Nargolwalla & Isabelle Labarre

Chapter 6 Germany
Oswin Ridderbusch

Chapter 7 Hungary
Adam Svingor

Chapter 8 Ireland
Donal M. Kelly

Chapter 9 Italy
Elisa Turri & Olga Capasso

Chapter 10 The Netherlands
Martin Klok

Chapter 11 Poland
Marta Kawczynska

Chapter 12 Spain
Juan Arias

Chapter 13 Sweden
Niklas Mattsson

Chapter 14 Switzerland
Philipp Marchand

Chapter 15 United Kingdom
Daniel Lim, Kate Taylor & Claire Baldock

Chapter 16 United States of America
John C. Todaro & Michele M. Wales

Chapter 17 Canada
Graeme Boocock & Charles A. Boulakia

Chapter 18 Mexico
Héctor E. Chagoya-Cortes & Israel Jiménez

Chapter 19 Andean Community: Bolivia, Colombia, Ecuador, and Peru
Andres Rincon, Carolina Vargas & Sergio Arboleda

Chapter 20 Argentina
Martin Bensadon & Cristian D. Bittel

Chapter 21 Brazil
Maria Carmen de Souza Brito & Pedro Henrique Borges de Figueiredo

Chapter 22 Chile
Rodrigo Marré Grez & Allison Ortega del Valle

Chapter 23 China
Gesheng Huang

Chapter 24 India
Mamta Rani Jha

Chapter 25 Israel
David Gilat & Mirit Lotan

Chapter 26 Japan
Takashi Fujita & Osamu Yamamoto

Chapter 27 Singapore
Kian Hoe Khoo

Chapter 28 South Korea
Min Son

Chapter 29 Taiwan
Paul C.C. Chen, Yih-Lin Chung, Arpita Dutta & Wei-Ting Liao

Chapter 30 Australia and New Zealand
Michael Christie

Table of Cases
  © 2017 Jure AB